DeSilva Nishan M
Insider CIK 1492386 · SELB Director · LGND VP, Finance & Strategy and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics, In | A Award deriv | 2026-01-02 | 2026-01-06 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2026-01-02 | 2026-01-06 | 2,600 | — | $0 | 11,366 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2025-01-02 | 2025-01-06 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2025-01-02 | 2025-01-06 | 2,600 | — | $0 | 8,766 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2024-01-02 | 2024-01-04 | 228,000 | — | $0 | 228,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2024-01-02 | 2024-01-04 | 178,000 | — | $0 | 185,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 80,000 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 40,000 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | D To issuer deriv | 2023-11-13 | 2023-11-15 | 75,000 | $0.93 | $69.8K | 0 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2023-01-02 | 2023-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2022-01-03 | 2022-01-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | P Buy | 2021-12-02 | 2021-12-06 | 7,000 | $2.96 | $20.7K | 7,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2021-06-23 | 2021-07-09 | 80,000 | — | $0 | 80,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-05-14 | 2015-05-14 | 20,938 | — | $0 | 24,062 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-05-14 | 2015-05-14 | 20,938 | $74.42 | $1.56M | 43,220 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-14 | 2015-05-14 | 20,938 | $83.84 | $1.76M | 22,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-05-13 | 2015-05-14 | 12,148 | — | $0 | 23,546 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-05-13 | 2015-05-14 | 11,757 | — | $0 | 64,029 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-13 | 2015-05-14 | 11,757 | $83.32 | $979.6K | 22,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-05-13 | 2015-05-14 | 11,757 | $14.47 | $170.1K | 34,039 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-13 | 2015-05-14 | 12,148 | $83.23 | $1.01M | 22,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-05-13 | 2015-05-14 | 12,148 | $21.92 | $266.3K | 34,430 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-05-12 | 2015-05-14 | 14,214 | — | $0 | 75,786 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2015-05-12 | 2015-05-14 | 9,306 | — | $0 | 35,694 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-12 | 2015-05-14 | 9,306 | $84.91 | $790.2K | 22,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-05-12 | 2015-05-14 | 9,306 | $21.92 | $204.0K | 31,588 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-05-12 | 2015-05-14 | 14,214 | $84.44 | $1.20M | 22,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2015-05-12 | 2015-05-14 | 14,214 | $14.47 | $205.7K | 36,496 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2015-02-10 | 2015-02-11 | 20,873 | $56.26 | $1.17M | 20,873 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2015-02-10 | 2015-02-11 | 2,300 | $56.34 | $129.6K | 16,359 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2015-02-10 | 2015-02-11 | 5,923 | — | $0 | 22,282 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 5,000 | $74.42 | $372.1K | 40,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 35,000 | $74.42 | $2.60M | 35,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2014-02-12 | 2014-02-14 | 5,000 | $74.42 | $372.1K | 45,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2014-02-12 | 2014-02-14 | 3,000 | — | $0 | 18,659 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | P Buy | 2013-06-28 | 2013-07-01 | 169 | $17.36 | $2.9K | 15,659 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-19 | 40,626 | $21.92 | $890.5K | 40,626 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-19 | 4,374 | $21.92 | $95.9K | 4,374 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-02-15 | 2013-02-19 | 5,000 | — | $0 | 15,490 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | J Other | 2012-12-31 | 2013-01-03 | 490 | $14.54 | $7.1K | 10,490 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 30,765 | $14.47 | $445.2K | 30,765 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 15,000 | $14.47 | $217.1K | 59,235 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 44,235 | $14.47 | $640.1K | 44,235 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2012-02-09 | 2012-02-13 | 10,000 | — | $0 | 10,000 | SEC↗ |